Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilent TechnologiesMEX:A 89 5-Year Yield-on-Cost % is 1.05 as of Jul. 15, 2026, which is 1% above its 10-year median of 1.04. GuruFocus rates MEX:A with a GF Score™ of 89/100 and a GF Value™ of MXN2,535.46 (Fairly Valued). The stock has 1 warning sign investors should review. Among 64 Medical Diagnostics & Research companies, Agilent Technologies ranks worse than 73.44% on this metric.
Agilent Technologies's yield on cost for the quarter that ended in Apr. 2026 was 1.05.
The historical rank and industry rank for Agilent Technologies's 5-Year Yield-on-Cost % or its related term are showing as below:
MEX:A'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.59 Med: 1.04 Max: 1.44
Current: 1.05
During the past 13 years, Agilent Technologies's highest Yield on Cost was 1.44. The lowest was 0.59. And the median was 1.04.
MEX:A's 5-Year Yield-on-Cost % is ranked worse than 73.44% of 64
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.455
vs MEX:A: 1.05
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Agilent Technologies 5-Year Yield-on-Cost % Related Terms
MEX:A vs NTRA, WAT, IDXX: 5-Year Yield-on-Cost % Comparison
For the Diagnostics & Research subindustry, Agilent Technologies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Agilent Technologies (MEX:A) has a 5-Year Yield-on-Cost % of 1.05 as of Jul. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Agilent Technologies and its competitors. This is near median its historical median of 1.04. Over the past decade, Agilent Technologies' 5-Year Yield-on-Cost % has ranged from 0.59 to 1.44. According to the industry distribution chart, Agilent Technologies ranks #47 out of 64 companies in the Medical Diagnostics & Research industry, placing it in the top 73.4%.
Is Agilent Technologies' 5-Year Yield-on-Cost % too high?
Agilent Technologies' current 5-Year Yield-on-Cost % of 1.05 is near median its 10-year median of 1.04. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 1.44. The Medical Diagnostics & Research industry median 5-Year Yield-on-Cost % is 2.46. Agilent Technologies' value of 1.05 is 57.2% below this industry median. Based on the distribution chart, Agilent Technologies ranks #47 out of 64 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Agilent Technologies has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' 5-Year Yield-on-Cost % compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #47 out of 64 companies for 5-Year Yield-on-Cost %. This places Agilent Technologies in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.46. Agilent Technologies' value of 1.05 is 57.2% below this benchmark. Historically, Agilent Technologies' own 5-Year Yield-on-Cost % has ranged from 0.59 to 1.44 over the past decade. While the company's 10-year median is 1.04 vs. the industry median of 2.46, Agilent Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.46, based on 64 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilent Technologies's current 5-Year Yield-on-Cost % of 1.05 is 57.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Agilent Technologies and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilent Technologies's current 5-Year Yield-on-Cost % is 1.05, which is near median its own 10-year median of 1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (MEX:A) is currently considered Fairly Valued. The stock's GF Value™ is MXN2,535.46, compared to a current price of MXN2,350.00 — trading 7.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.05, which is near median its 10-year median of 1.04 and 57.2% below the Medical Diagnostics & Research industry median of 2.46. Agilent Technologies' overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Agilent Technologies (MEX:A), the current 5-Year Yield-on-Cost % is 1.05 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (MEX:A) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of MXN2,350.00 is trading 7.3% below its estimated GF Value™ of MXN2,535.46.
GuruFocus considers Agilent Technologies to be Fairly Valued.
Key valuation signals for MEX:A:
5-Year Yield-on-Cost %: 1.05 (near median its 10-year median of 1.04)
GF Value™: MXN2,535.46 vs. price of MXN2,350.00 (7.3% below fair value)
Industry Position: 57.2% below the Medical Diagnostics & Research median (#47 of 64)
No single metric tells the full story. See the MEX:A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
89GF Score
Get the complete analysis for MEX:A
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:A has been successfully added to your 
